DK1761495T3 - Piperidinylprostaglandinanaloge som midler til nedsættelse af øjets indre tryk - Google Patents

Piperidinylprostaglandinanaloge som midler til nedsættelse af øjets indre tryk

Info

Publication number
DK1761495T3
DK1761495T3 DK05749871.9T DK05749871T DK1761495T3 DK 1761495 T3 DK1761495 T3 DK 1761495T3 DK 05749871 T DK05749871 T DK 05749871T DK 1761495 T3 DK1761495 T3 DK 1761495T3
Authority
DK
Denmark
Prior art keywords
eye
agents
reducing
internal pressure
prostaglandin analogues
Prior art date
Application number
DK05749871.9T
Other languages
English (en)
Inventor
David W Old
Danny T Dinh
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergan Inc filed Critical Allergan Inc
Application granted granted Critical
Publication of DK1761495T3 publication Critical patent/DK1761495T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D211/74—Oxygen atoms
    • C07D211/76—Oxygen atoms attached in position 2 or 6
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576—Six-membered rings
    • C07F9/59—Hydrogenated pyridine rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK05749871.9T 2004-06-04 2005-05-16 Piperidinylprostaglandinanaloge som midler til nedsættelse af øjets indre tryk DK1761495T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57736104P 2004-06-04 2004-06-04
PCT/US2005/017167 WO2005121086A2 (en) 2004-06-04 2005-05-16 Piperidinyl prostaglandin analogs as ocular hypotensive agents

Publications (1)

Publication Number Publication Date
DK1761495T3 true DK1761495T3 (da) 2012-06-18

Family

ID=35431920

Family Applications (1)

Application Number Title Priority Date Filing Date
DK05749871.9T DK1761495T3 (da) 2004-06-04 2005-05-16 Piperidinylprostaglandinanaloge som midler til nedsættelse af øjets indre tryk

Country Status (9)

Country Link
US (1) US7435746B2 (da)
EP (1) EP1761495B1 (da)
AT (1) ATE550323T1 (da)
AU (1) AU2005252171A1 (da)
CA (1) CA2569464C (da)
DK (1) DK1761495T3 (da)
ES (1) ES2381377T3 (da)
PL (1) PL1761495T3 (da)
WO (1) WO2005121086A2 (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7326716B2 (en) * 2003-06-06 2008-02-05 Allergan, Inc. Treatment of inflammatory bowel disease

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1408961B1 (en) * 2001-07-16 2007-07-11 F. Hoffmann-La Roche Ag 2 pyrrolidone derivatives as prostanoid agonists
EP1461026A2 (en) * 2001-12-03 2004-09-29 Merck & Co., Inc. Method for treating ocular hypertension
WO2003077910A1 (en) * 2002-03-18 2003-09-25 Pfizer Products Inc. Methods of treatment with selective ep4 receptor agonists
US6573294B1 (en) * 2002-05-14 2003-06-03 Allergan, Inc. 8-azaprostaglandin analogs as agents for lowering intraocular pressure
BRPI0406717A (pt) * 2003-01-10 2005-12-20 Hoffmann La Roche Composto, composição farmacêutica que compreende o mesmo, método de tratamento de uma enfermidade em um mamìfero, utilização do composto e processo para a sua produção
JP2006527189A (ja) * 2003-06-06 2006-11-30 アラーガン、インコーポレイテッド ピペリジニルプロスタグランジンｅ類似体

Also Published As

Publication number Publication date
CA2569464C (en) 2012-10-23
WO2005121086A2 (en) 2005-12-22
ES2381377T3 (es) 2012-05-25
PL1761495T3 (pl) 2012-07-31
EP1761495A2 (en) 2007-03-14
US20060281713A1 (en) 2006-12-14
EP1761495B1 (en) 2012-03-21
AU2005252171A1 (en) 2005-12-22
WO2005121086A3 (en) 2006-04-27
CA2569464A1 (en) 2005-12-22
US7435746B2 (en) 2008-10-14
ATE550323T1 (de) 2012-04-15

Similar Documents

Publication Publication Date Title
NO20080865L (no) Spirokromanonderivater som acetyl-koenzym-A-karboksylase(ACC)inhibitorer
NO20083434L (no) Benzamid- og heteroarenderivater
NO20092587L (no) LXR og FXR modulatorer
CY1119261T1 (el) Παραγωγα θειαζολιου
CL2024000067A1 (es) Compuestos antivirales
PH12022553603A1 (en) Triazine derivative having virus propagation inhibitory effect, and pharmaceutical composition containing same
NO20073357L (no) 5-karboksamid substituerte tiazol derivater som reagerer med ionekanaler, i saerdeleshet med ionekanaler fra Kv familien
NO20083726L (no) Spiroindolinon derivater
EA201000805A1 (ru) Бис-(сульфониламино)производные в терапии 066
ATE519764T1 (de) Spiroindolinon-derivate
NO20090835L (no) Nye HIV-reverstranskriptaseinhibitorer
EA200970856A1 (ru) Ингибиторы пути хеджхога
NI200700102A (es) Derivados de indol tetraciclicos como agentes antiviricos
MX2009001659A (es) Compuestos de 2,5-dihidroxibenceno para el tratamiento de rosacea.
SE0400284D0 (sv) Novel compounds
WO2008008660A3 (en) Cyclopentane derivatives as antiglaucoma agents
WO2008008718A3 (en) Cyclopentane derivatives as antiglaucoma agents
DK1753723T3 (da) Substituerede quinolinderivater som mitotiske kinesininhibitorer
TW200728260A (en) Substituted-(quinazolinyl)phenyl thiophenyl-sulfonylureas, methods for making and intermediates thereof
MX2009010302A (es) Derivados de indol que tienen actividad inhibidora de cpla2 y aplicaciones y metodos de produccion.
DE602006011752D1 (de) Als antikoagulationsmittel geeignete phenylglycinamid- und pyridylglycinamidderivate
UY27803A1 (es) Derivados de benzoxazina y usos de los mismos.
TNSN08369A1 (en) Benzimidazole derivatives
JOP20250214A1 (ar) مشتقات هيدروكينازولين لعلاج مرض أو اضطراب
NO20054135L (no) Kipolinon/benzoksazin derivater og anvendelser derav